| abstract |
Compound for use in the treatment of chronic obstructive pulmonary disease selected from: ((S) -3,3,3-trifluoro-2-hydroxy-2-methyl-propyl) -amide of 3-amino-6-methoxy-acid 5-trifluoro-methyl-pyridine-2-carboxylic acid; 3-Amino-6-methoxy-5-trifluoro-methyl-pyridine-2-carboxylic acid ((R) -3,3,3-trifluoro-2-hydroxy-2-methyl-propyl) -amide; 3-Amino-6- (4-fluoro-phenyl) -5-trifluoro-methyl-pyridine-2-carboxylic acid (3,3,3-trifluoro-2-hydroxy-2-methyl-propyl) -amide; 3-Amino-5,6-bis-trifluoro-methyl-pyridine-2-carboxylic acid ((S) -3,3,3-trifluoro-2-hydroxy-2-methyl-propyl) -amide and ((R 3-Amino-5,6-bis-trifluoro-methyl-pyridine-2-carboxylic acid -3,3,3-trifluoro-2-hydroxy-2-methyl-propyl) -amide; or a pharmaceutically acceptable salt thereof. |